FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC Holdings

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC is an investment fund managing more than 33.31M US dollars. The largest holdings include Pardes Biosciences, Theseus Pharmaceuticals and Gemini Therapeutics. In Q2 2022 the fund bought assets of total value of 3.9M US dollars and sold assets of total value of 13.61M US dollars.

$33.30M

portfolio value

-16.06%

quarter

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2022	1619000	18755000
Q2 2022	3900000	13611000

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Pardes Biosciences, Inc. Portfolio share: 29.04% Portfolio value: 9.67M Avg. open price: N/A Current price: $1.1 P/L: N/A N/A Q4 2021	share	29.04%	9.67M	N/A	$1.1	N/A	N/A Q4 2021
Biotechnology Theseus Pharmaceuticals, Inc. Portfolio share: 16.71% Portfolio value: 5.56M Avg. open price: $11.53 Current price: $6.03 P/L: -47.70% Bought +104.61% shares Q2 2022	share	16.71%	5.56M	$11.53	$6.03	-47.70%	Bought +104.61% shares Q2 2022
Biotechnology Gemini Therapeutics, Inc. Portfolio share: 11.99% Portfolio value: 3.99M Avg. open price: N/A Current price: $1.7 P/L: N/A N/A Q4 2021	share	11.99%	3.99M	N/A	$1.7	N/A	N/A Q4 2021
Biotechnology Compass Therapeutics, Inc. Portfolio share: 10.64% Portfolio value: 3.54M Avg. open price: $1.37 Current price: $4.53 P/L: +230.66% Bought +41.30% shares Q2 2022	share	10.64%	3.54M	$1.37	$4.53	+230.66%	Bought +41.30% shares Q2 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 10.46% Portfolio value: 3.48M Avg. open price: N/A Current price: $7.05 P/L: N/A N/A Q4 2021	share	10.46%	3.48M	N/A	$7.05	N/A	N/A Q4 2021
Biotechnology Adicet Bio, Inc. Portfolio share: 7.26% Portfolio value: 2.41M Avg. open price: N/A Current price: $20.2 P/L: N/A N/A Q4 2021	share	7.26%	2.41M	N/A	$20.2	N/A	N/A Q4 2021
Biotechnology Quantum-Si incorporated Portfolio share: 5.23% Portfolio value: 1.74M Avg. open price: N/A Current price: $2.36 P/L: N/A Sold -60.35% shares Q2 2022	share	5.23%	1.74M	N/A	$2.36	N/A	Sold -60.35% shares Q2 2022
Household & Personal Products Hims & Hers Health, Inc. Portfolio share: 5.13% Portfolio value: 1.71M Avg. open price: N/A Current price: $6.71 P/L: N/A N/A Q2 2022	share	5.13%	1.71M	N/A	$6.71	N/A	N/A Q2 2022
Biotechnology Enanta Pharmaceuticals, Inc. Portfolio share: 3.54% Portfolio value: 1.18M Avg. open price: N/A Current price: $43.06 P/L: N/A N/A Q1 2022	share	3.54%	1.18M	N/A	$43.06	N/A	N/A Q1 2022

Showing TOP 9 FORESITE CAPITAL OPPORTUNITY MANAGEMENT V's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC?

The biggest position of the FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC is Pardes Biosciences, Inc. (PRDS) with 29.04% portfolio share worth of 9.67M US dollars.

Top 5 FORESITE CAPITAL OPPORTUNITY MANAGEMENT V's holdings represent 78.84% of the portfolio:

Pardes Biosciences, Inc. (PRDS) – 29.04%
Theseus Pharmaceuticals, Inc. (THRX) – 16.71%
Gemini Therapeutics, Inc. (GMTX) – 11.99%
Compass Therapeutics, Inc. (CMPX) – 10.64%
Kinnate Biopharma Inc. (KNTE) – 10.46%

Who is the portfolio manager of FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC?

The portfolio manager of the FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC is .

What is the total asset value of the FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC portfolio?

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC total asset value (portfolio value) is 33.31M US dollars.

Who is ?

is the portfolio manager of the FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC.

What is (FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC) fund performance?

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V's quarterly performance is -16.06%, annualy 0.00%.

What is the FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC CIK?

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V's Central Index Key is 0001792207 .